| Sep 26 |
AZN's Tagrisso Gets FDA Nod for Expanded Use in NSCLC
|
| Sep 26 |
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
|
| Sep 26 |
AstraZeneca gets FDA expanded approval for Tagrisso
|
| Sep 26 |
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
| Sep 26 |
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
|
| Sep 26 |
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
| Sep 26 |
TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
|
| Sep 25 |
Has Arbutus Biopharma (ABUS) Outpaced Other Medical Stocks This Year?
|
| Sep 25 |
AstraZeneca PLC (AZN): A Risky Bet on Emerging Cancer Treatments
|
| Sep 24 |
AZN Stock Slips as Dato-DXd Cancer Study Misses Survival Goal
|
